These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15894587)

  • 1. Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation.
    Cruise MW; Melief HM; Lukens J; Soguero C; Hahn YS
    J Leukoc Biol; 2005 Aug; 78(2):412-25. PubMed ID: 15894587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver.
    Watanabe T; Yoshida M; Shirai Y; Yamori M; Yagita H; Itoh T; Chiba T; Kita T; Wakatsuki Y
    J Immunol; 2002 Mar; 168(5):2188-99. PubMed ID: 11859105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of activated CD4+ and CD8+ T cells is enhanced by co-culture with hepatocytes expressing hepatitis C virus (HCV) structural proteins through FasL induction.
    Iken K; Huang L; Bekele H; Schmidt EV; Koziel MJ
    Virology; 2006 Mar; 346(2):363-72. PubMed ID: 16336987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage.
    Cruise MW; Lukens JR; Nguyen AP; Lassen MG; Waggoner SN; Hahn YS
    J Immunol; 2006 May; 176(10):6235-44. PubMed ID: 16670334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction.
    Gremion C; Grabscheid B; Wölk B; Moradpour D; Reichen J; Pichler W; Cerny A
    J Virol; 2004 Feb; 78(4):2152-7. PubMed ID: 14747581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.
    Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T
    Hum Immunol; 2003 Feb; 64(2):224-30. PubMed ID: 12559624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver damage by infiltrating CD8+ T cells is Fas dependent.
    Kennedy NJ; Russell JQ; Michail N; Budd RC
    J Immunol; 2001 Dec; 167(11):6654-62. PubMed ID: 11714837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein.
    Ruggieri A; Murdolo M; Rapicetta M
    Virus Res; 2003 Nov; 97(2):103-10. PubMed ID: 14602201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a murine CD4+ T-lymphocyte response site in hepatitis C virus core protein.
    Chen Z; Berkower I; Ching WM; Wang RY; Alter HJ; Shih JW
    Mol Immunol; 1996; 33(7-8):703-9. PubMed ID: 8760282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.
    Pinkoski MJ; Droin NM; Lin T; Genestier L; Ferguson TA; Green DR
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16174-9. PubMed ID: 12454289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
    J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner.
    Janssens W; Carlier V; Wu B; VanderElst L; Jacquemin MG; Saint-Remy JM
    J Immunol; 2003 Nov; 171(9):4604-12. PubMed ID: 14568934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
    Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
    J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization.
    Klugewitz K; Blumenthal-Barby F; Schrage A; Knolle PA; Hamann A; Crispe IN
    J Immunol; 2002 Sep; 169(5):2407-13. PubMed ID: 12193708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptides.
    Langhans B; Schweitzer S; Braunschweiger I; Schulz M; Sauerbruch T; Spengler U
    Cytometry A; 2005 May; 65(1):59-68. PubMed ID: 15800857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model.
    Soguero C; Joo M; Chianese-Bullock KA; Nguyen DT; Tung K; Hahn YS
    J Virol; 2002 Sep; 76(18):9345-54. PubMed ID: 12186917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel model of antigen-specific induction of bile duct injury.
    Buxbaum J; Qian P; Khuu C; Shneider BL; Daikh DI; Gershwin ME; Allen PM; Peters MG
    Gastroenterology; 2006 Dec; 131(6):1899-906. PubMed ID: 17087941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naive CD4+ T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen.
    Ise W; Totsuka M; Sogawa Y; Ametani A; Hachimura S; Sato T; Kumagai Y; Habu S; Kaminogawa S
    J Immunol; 2002 Apr; 168(7):3242-50. PubMed ID: 11907078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.